HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wen Ping Li Selected Research

DOTA-Tyr(1)-octreotate

7/2002DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wen Ping Li Research Topics

Disease

3Neoplasms (Cancer)
06/2019 - 07/2002
1Carcinoma (Carcinomatosis)
06/2019
1Squamous Cell Carcinoma of Head and Neck
06/2019
1Disease Progression
06/2019
1Breast Neoplasms (Breast Cancer)
02/2006
1Melanoma (Melanoma, Malignant)
02/2006

Drug/Important Bio-Agent (IBA)

1Messenger RNA (mRNA)IBA
06/2019
1Matrix Metalloproteinases (MMPs)IBA
02/2006
1CTTHWGFTLC peptideIBA
02/2006
1Peptides (Polypeptides)IBA
02/2006
1GelatinasesIBA
02/2006
1MetalsIBA
07/2002
1Pentetic Acid (DTPA)FDA LinkGeneric
07/2002
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
07/2002
1Radioisotopes (Radionuclides)IBA
07/2002
1Chelating AgentsIBA
07/2002
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
07/2002
1DOTA-Tyr(1)-octreotateIBA
07/2002
1Somatostatin Receptors (Somatostatin Receptor)IBA
07/2002
1HalogensIBA
07/2002
1IodineIBA
07/2002
1N-acetyltalosaminuronic acid (NAT)IBA
07/2002

Therapy/Procedure

2Therapeutics
02/2006 - 07/2002